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Abstract
Mesolimbic dopamine neurons fire in both tonic and phasic modes resulting in detectable
extracellular levels of dopamine in the nucleus accumbens (NAc). In the past, different techniques
have targeted dopamine levels in the NAc to establish a basal concentration. In this study we used
in vivo fast scan cyclic voltammetry (FSCV) in the NAc of awake, freely moving rats. The
experiments were primarily designed to capture changes in dopamine due to phasic firing – that is,
the measurement of dopamine ‘transients’. These FSCV measurements revealed for the first time
that spontaneous dopamine transients constitute a major component of extracellular dopamine
levels in the NAc. A series of experiments were designed to probe regulation of extracellular
dopamine. Lidocaine was infused into the ventral tegmental area, the site of dopamine cell bodies,
to arrest neuronal firing. While there was virtually no instantaneous change in dopamine
concentration, longer sampling revealed a decrease in dopamine transients and a time-averaged
decrease in the extracellular level. Dopamine transporter (DAT) inhibition using intravenous
GBR12909 injections increased extracellular dopamine levels changing both frequency and size of
dopamine transients in the NAc. To further unmask the mechanics governing extracellular
dopamine levels we used intravenous injection of the vesicular monoamine transporter (VMAT2)
inhibitor, tetrabenazine, to deplete dopamine storage and increase cytoplasmic dopamine in the
nerve terminals. Tetrabenazine almost abolished phasic dopamine release but increased
extracellular dopamine to ~500 nM, presumably by inducing reverse transport by DAT. Taken
together, data presented here show that average extracellular dopamine in the NAc is low (20–30
nM) and largely arises from phasic dopamine transients.
INTRODUCTION
Dopaminergic neurons normally fire in a slow (3–7 Hz), tonic fashion, but periodically they
fire more rapidly (≥ 20 Hz) in a phasic manner for a brief interval before resuming tonic
firing (Floresco et al. 2003, Grace & Bunney 1984b, Grace & Bunney 1984a, Schultz et al.
1993, Hyland et al. 2002). Similar terms (e.g. tonic/phasic) have been used to describe
extracellular concentrations of dopamine. However, it is unclear how different firing modes
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relate to extracellular dopamine levels. Phasic firing of dopaminergic neurons is triggered in
several ways, including activation of NMDA receptors in the cell body regions (Chergui et
al. 1993), and often occurs in response to salient stimuli that are associated with reward
(Schultz et al. 1997, Pan et al. 2005). Similar stimuli result in dopamine concentration
transients in regions with dopamine terminals (Robinson et al. 2002, Phillips et al. 2003,
Stuber et al. 2005, Day et al. 2007, Roitman et al. 2008), and these transients are both
necessary (Zweifel et al. 2009) and sufficient (Tsai et al. 2009) for reward related behaviors.
Like phasic firing, dopamine transients also depend on functional NMDA receptors in the
VTA and they can be evoked by electrical stimuli that mimic phasic bursts (Sombers et al.
2009). Thus, phasic firing and dopamine concentration transients are tightly coupled.
The overall contribution of phasic and tonic firing establishes a basal level of extracellular
dopamine. Complete removal of extracellular dopamine leads to Parkinson-like conditions
(Berke & Hyman 2000) supporting a functional role for basal dopamine. However,
establishing the magnitude of extracellular dopamine has proved technically difficult
(reviewed in (Watson et al. 2006)). Early estimates with slow electrochemical techniques for
the extracellular striatal dopamine concentration were ~25 nM (Gonon & Buda 1985). More
modern techniques such as FSCV, as well as other rapid electrochemical methods, have a
large background that must be removed before the current due to dopamine is resolved.
Thus, these methods only yield differential concentrations. Estimates of the extracellular
striatal extracellular dopamine concentration from these types of experiments range from 6
nM (Kawagoe et al. 1992) to 2.5 μM (Borland & Michael 2004, Kulagina et al. 2001), with
intermediate values also proposed (Chen & Budygin 2007). Basal concentrations of striatal
dopamine evaluated by no-net flux microdialysis sampling have been reported to be in the
low nanomolar range (Justice 1993, Shou et al. 2006). However, these values may be an
underestimate due to tissue damage caused by probe insertion (Bungay et al. 2003, Yang et
al. 1998). Thus, while there is considerable variability in reports of the average extracellular
level, data seem to have coalesced around the low nanomolar range (Dreyer et al. 2010). It
remains unclear, though, whether this level is established largely by tonic or phasic
dopamine neuronal firing.
Here we address the contribution of dopamine transients to the average extracellular
concentration of dopamine in the NAc with FSCV. To accomplish this, we recorded
dopamine transients in the brain of awake rats at rest. When signal averaged over multiple
minutes, we obtained an extracellular level similar to those previously reported using
microdialysis. To suppress both tonic and phasic firing, lidocaine was microinfused into the
ventral tegmental area. This microinfusion significantly lowered the time-averaged
extracellular dopamine level without affecting the instantaneous level. We then
characterized how inhibition of DAT and increased cytoplasmic dopamine altered
extracellular dopamine levels and dopamine transients. Together, these experiments indicate
that under normal circumstances, extracellular dopamine is quite low (20–30 nM) and a




Male Sprague Dawley rats (Harlan Sprague Dawley, Indianapolis, IN) weighing 275–350 g
were used as subjects and individually housed with a 12:12 light: dark cycle (lights on at 6
am) with access to food and water ad libitum. All experiments were conducted between 9:00
am and 5:00 pm. For some experiments, rats (n = 10) purchased with intravenous catheters
were used (Charles River, Wilmington, MA). All procedures were approved by the
University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee.
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Rats were surgically prepared for voltammetric recordings as described previously (Phillips
et al. 2003; Roitman et al. 2004). Rats were anesthetized with isoflurane; rats were induced
at 4% and maintained at 1.5–2.0% during surgery. Rats were secured in a stereotaxic frame
for implantation of a guide cannula (Bioanalytical Systems, West Lafayette, IL) that was
positioned 2.5 mm deep into the brain over the core subregion of the NAc (+1.3 AP, 1.3 ML
from bregma). A chlorinated silver electrode (Ag/AgCl) was placed contralateral to the
guide cannula in the forebrain to serve as a reference. A bipolar stimulating electrode
(Plastics One, West Lafayette, IN) was positioned just dorsal to the ventral tegmental area
(−5.2 AP, 1.0 ML from bregma and 7.8 mm ventral from the dural surface of the brain). For
lidocaine infusion experiments, the microinfusion guide cannula (C315G-MS303/2/SPC,
Plastics One, West Lafayette, IN) was located between the bipolar tips to ensure
introduction of the drug into the appropriate region. Stainless steel skull screws and dental
cement were used to secure all items. Postoperatively, rats were closely monitored and
received ibuprofen (15 mg/kg).
Fast-scan cyclic voltammetry
Following surgery, animals were allowed 2 days to recover to pre-surgery body weight. A
detachable micromanipulator containing a glass-sealed carbon-fiber electrode (75–100 μm
exposed tip length, 7 μm diameter, T-650; Amoco, Greenville, SC) was inserted into the
guide cannula and the electrode was lowered into the NAc core. Electrical stimulations (24
biphasic pulses, 60 Hz, 125 μA, 2 ms per phase) to the VTA were applied as the carbon-
fiber microelectrode was lowered to ensure it was in a location that supported robust
dopamine release (Wightman et al. 2007).
The carbon-fiber and Ag/AgCl electrodes were connected to a head-mounted voltammetric
amplifier attached to a commutator (Crist Instrument Company, Hagerstown, MD) at the top
of the experimental chamber. Electrochemical data were digitized and stored using computer
software written in LabVIEW (National Instruments, Austin, TX). The potential of the
carbon-fiber electrode was held at −0.4 V versus the Ag/AgCl reference electrode.
Voltammetric recordings were made by applying a triangular waveform that drove the
potential to +1.3 V and back at a rate of 400 V/s. To minimize current drift and to enhance
sensitivity, the carbon-fiber electrode was allowed to equilibrate for 30–45 min with
voltammetric scanning at 60 Hz prior to the start of the experiment (Takmakov et al. 2010).
During data acquisition, the repetition rate was 10 Hz. Dopamine release was electrically
evoked by stimulating the VTA (24 biphasic pulses, 60 Hz, 125 μA, 2 ms per phase).
Drugs and Local microperfusion
Local infusion of drugs (Sigma Aldrich) employed a syringe pump (Kent Scientific
Corporation,0.5 μl injected for 60 s) with an infusion cannulae(33 gauge) inserted into the
unilaterally implanted guide. Microinfusions were of saline (0.9 %) or lidocaine (350 nmol/
0.5 μl, dissolved in saline with the pH adjusted to 6.0 with NaOH). The microinfusion
needle was inserted before the experiment started to reduce handling or other sources of
noise. After two minutes of baseline lidocaine was infused for one minute. Following
infusion the needle was removed.
GBR 12909-HCl (Tocris) was dissolved in 0.1 mL of distilled water and then diluted to 1
mL with saline. The vehicle was prepared similarly. The dose of GBR 12909 selected (1.5
mg/kg i.v.) caused a moderate increase in locomotor activity. Tetrabenazine was dissolved
in 50% ethanol and 50% distilled water. Vehicle was the 50:50 ethanol:distilled water that
was used to dissolve tetrabenazine. The dose of tetrabenazine used (1 mg/kg) was selected
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because it caused immobility of the animal without inducing catalepsy. All injection
volumes were 0.3 ml.
Signal analysis
Background currents were removed by subtraction of cyclic voltammograms recorded over
1 s. For the evaluation of electrically stimulated release, the background was taken in the
interval before the stimulation. To determine the time averaged concentration arising from
dopamine transients, cyclic voltammograms were continuously collected for 15 min. These
data were broken into 30 s epochs and for each epoch the set of cyclic voltammograms
during 1 s around the local minimum served as the background. For each rat, all 30 s epochs
(30 epochs) were averaged together to obtain an average 30 s concentration trace. Each rat’s
average trace was then averaged together to obtain means and standard errors.
To understand how time-averaging alters the variability of dopamine concentration, we
calculated the coefficient of variation of dopamine concentration for each rat when data
were averaged across different bin sizes. For the 0.1s bin, all 9000 CVs were averaged for
each rat and a mean and standard deviation was obtained. For the 1s bin, first every 10
cyclic voltammograms were averaged to obtain a single value for each 1s bin and then data
were averaged across 900 bins to obtain a mean and standard deviation for each rat. For the
5s bin, the procedure was similar except 50 cyclic voltammograms were averaged to obtain
a single value for each 5s bin. Likewise, every 100 cyclic voltammograms were averaged for
the 10 s bin followed by averaging over 90 bins to obtain a mean and standard deviation for
each rat. Identical procedures were followed to compute the 15 and 30 s bins. The
coefficient of variation (standard deviation/mean) was determined for each bin size for each
rat.
Before and after in vivo recordings, dopamine release was evoked by VTA stimulation to
provide a training set for principal component regression (Keithley et al. 2010a, Keithley et
al. 2009, Heien et al. 2004, Keithley et al. 2010b). Stimulation of the VTA leads to two well
established electrochemical events: an immediate but transient increase in dopamine and a
delayed but longer-lasting basic pH shift. The training set was constructed from
representative, background-subtracted cyclic voltammograms for dopamine and pH. This
training set was used to perform principal component regression on data collected during the
recording session. The calibration factors used to convert cyclic voltammetry currents into
concentration were obtained after in vivo use in physiological buffer (Heien et al. 2003).
Because the electrodes were used to make electrical lesions at the end of the experiment, the
calibration factor (12 nA/μM for dopamine, −40nA/pH unit) used were the average obtained
from more than 25 electrodes used in prior work. A residual analysis procedure was used to
verify that the cyclic voltammograms of the trials being predicted were consistent with the
analyte cyclic voltammograms used for calibration. Any trials containing uncharacteristic
variance larger than 95% of the noise of the training set were discarded (Keithley et al.
2009, Keithley et al. 2010b). Dopamine events were termed transients if their concentration
was 5 times the standard deviation of the noise. The noise was calculated as the root mean
square amplitude in the first 1 s (10 scans) obtained in the beginning of the 30 s epoch. If
this interval contained a dopamine transient, the time for the noise calculation was moved to
a later time. One-way repeated-measures anovas were used to test for significant changes in
dopamine transient frequencies and for changes in stimulated dopamine release in different
treatment groups compared to naïve (pre-drug) values.
Histological verification of electrode placement
Upon completion of each experiment, rats were deeply anesthetized with urethane. To mark
the placement of electrode tips, the carbon-fiber microelectrode was removed and replaced
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with a tungsten electrode (Owesson-White et al. 2009). A 500 μA current was passed
through the electrode for 5 seconds to make a visible lesion. Transcardial perfusions were
then performed using physiological saline and 10% formalin, and the brains were removed.
The lesion site was assessed by visual examination of successive coronal sections.
Placement of an electrode tip within the NAc core was determined by examining the relative
position of the lesion to visual landmarks using the anatomical organization of the NAc
represented in a stereotaxic atlas (Paxinos & Watson 2007).
Results
Time-averaged Phasic Dopamine Signaling
Naïve rats (n = 9) were surgically prepared for voltammetric recordings. After recovery (at
least 2 days), rats were placed in a standard experimental chamber (Med Associates, St.
Albans, VT) and cyclic voltammograms were recorded in the NAc for 15 min. Dopamine
concentration changes during each 30 s interval were determined from the background-
subtracted cyclic voltammograms using principal component regression (Figure 1). Figure
1A shows the dopamine concentration fluctuations (top) extracted from these data (bottom)
by principal component regression. Occasional dopamine transients can be seen. These
spontaneous dopamine transients have been reported previously (Wightman et al. 2007), and
arise from brief phasic firing of dopamine neurons (Sombers et al. 2009).
The microdialysis technique, the approach that has been most used for measuring basal
dopamine concentrations, samples the extracellular fluid on a minutes time scale whereas
the background-subtracted cyclic voltammograms in Figure 1 were sampled at 0.1 s
intervals. To allow comparison of these data with microdialysis, we averaged together 30 s
epochs of cyclic voltammograms over 15 min. Figure 1B shows the average dopamine
concentration fluctuation (top) as well as a color representation of this average (bottom).
The averaging procedure smoothed out the transients and yielded an average concentration
of approximately 20 nM (18 ± 2, mean ± SEM). This is the average concentration over 15
min that is contributed by dopamine transients.
To illustrate how signal averaging results in the loss of variability in dopamine fluctuations
we examined the coefficient of variation for dopamine transients averaged over different
time epochs. For each rat, we calculated the concentration of dopamine over 15 min (30
consecutive 30 s samples) in different intervals (1, 5, 10, 15, 30s). For the individual
example shown in Figure 1C, the coefficient of variation decreased as the duration used to
time-average the data increased (β=−0.96; CI = −1.36 to −0.56, p<0.01), although there was
no effect on the average concentration of dopamine (not shown, 18.7 ± 2.0nM; β=−0.38; CI
= −1.67 to 0.89, p=0.44). For each rat, we calculated the coefficient of variation for 15 min
of data, averaged in 0.1, 1, 5, 10, 15 and 30s epochs. Figure 1D shows the average
coefficient of variation of 9 rats tested, with the unaveraged data yielding a higher
coefficient of variation than data time-averaged in 30 s bins. Across the population of rats
tested, average concentration of dopamine did not depend on the time interval used to
sample the data (β=0.00; CI = −0.23 to 0.23, p=0.99), but the coefficient of variation
decreased with increasing duration of interval (β=−0.53; CI = −0.74 to −0.32, p<0.0001).
These data support the idea that sampling over time, as in microdialysis, reduces the native
variability of dopamine concentration fluctuations.
Intra-VTA injection of lidocaine
Previously we have shown that inactivation of the VTA with microinfusions of lidocaine
significantly diminishes electrically stimulated release of dopamine and lowers the
frequency of spontaneous dopamine transients (Sombers et al. 2009). We repeated these
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experiments here to examine more closely any concentration changes that occurred at the
time of the local microinfusions (instantaneous) as well as to examine the effects of
lidocaine on the average concentration of dopamine. A separate group of rats (n = 7) was
surgically prepared as described above with the addition of an injection cannula between the
poles of the bipolar stimulating electrode. This modification ensures that the microinjection
site is at a location that supports electrically evoked release. After recovery from surgery,
rats were placed in the experimental chamber and a fresh carbon-fiber microelectrode was
inserted into the NAc at a location that supported stimulated release.
First, we recorded for 10 minutes to gather predrug voltammograms and these were grouped
into 30 s epochs. Immediately before microinfusion of saline or lidocaine, electrically
evoked dopamine release was measured. Then, 2 minutes later, a 1 minute microinfusion of
either saline or lidocaine was made while recording voltammograms. The voltammograms
collected during the microinfusion and for 9 minutes thereafter were also grouped into 30 s
epochs. Then, electrically evoked dopamine was measured again. Figure 2A–C shows a
representative example of the events measured around a single lidocaine microinfusion.
Electrically evoked dopamine release before lidocaine is accompanied by a small pH change
(black line for dopamine, blue trace for pH change, 2A).
Figure 2B shows the events that occurred in this representative animal during the one minute
lidocaine microinfusion and the subsequent minute. Neither dopamine nor pH changed
appreciably during the infusion or in the following minute. When evaluated in all 7 animals,
the average dopamine concentration change in the 2 minute interval during and after
lidocaine infusion was 0.5 ± 6.4 nM. Since no significant change was determined
immediately after the lidocaine microinfusion, the tonic level must be below the limits of
detection of fast-scan cyclic voltammetry. Ten minutes after lidocaine microinfusion, both
electrically evoked dopamine and pH were significantly attenuated, Figure 2C.
To evaluate the contribution of dopamine transients to the average concentration during the
10 minutes before microinfusions, the 30 s epochs were background subtracted and the
dopamine concentration was extracted as described above. These dopamine concentrations
were then averaged together from all animals. Similar processing was done for the data
collected in the 10 minutes during and after saline microinfusion and during and after
lidocaine infusion. In this group of animals, the average dopamine concentration arising
from transients was 23 ± 2 nM (Figure 2D), a value in good agreement with the previous
experiment (Figure 1). Following saline the average dopamine concentration was unchanged
(26 ± 2 nM, Figure 2E). However, following lidocaine infusion, the average dopamine
concentration due to transients was decreased (15 ± 2 nM, Figure 2F). The frequency of
dopamine transients was also compared across the three conditions. The number of
transients before saline was significantly higher than after lidocaine, and was reduced to
23% of the pre-drug value. There was a small reduction in transient frequency following
saline but it was not significantly different from the pre-drug value (Figure 2H). The
maximal dopamine concentration evoked by electrical stimulation, [DA]stim, was averaged
and compared across the three conditions. Saline caused an insignificant attenuation of
release relative to pre-infusion levels, but, following lidocaine microinfusions into the VTA,
electrically evoked dopamine release was significantly diminished, 23% of pre-drug (Figure
2G).
Dopamine extracellular levels after DAT inhibition
To examine the role of DAT in maintaining extracellular levels, we inhibited its function
with GBR 12909. The intravenous route was used to allow rapid access of drug to the brain.
Results from a single animal during GBR 12909 are shown in Figure 3A–C. DAT inhibition
increased stimulated dopamine release measured 10 min after drug administration (compare
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Figure 3A and C), a result that was seen in all animals (Figure 3D) and that is consistent
with measurement in anesthetized animals (Wightman et al. 1988). GBR 12909 caused a
rise in extracellular dopamine that was characterized by multiple, overlapping transients that
summed to give a substantial dopamine change that approached 400 nM (Figure 3B). This
response, increased transients and a large increase in extracellular dopamine, is also seen
following cocaine (Wightman et al. 2007). Figures 3D and 3E summarize the effect on
electrically evoked dopamine release and frequency of transients, n=5. GBR12909
significantly elevated both stimulated dopamine release and number of transients observed.
Administration of vehicle did not affect stimulated release or transient frequency (Figure
3D,E).
Dopamine extracellular levels following blockade of the vesicular transporter
Rats with intravenous catheters were also used to evaluate inhibition of vesicular dopamine
storage by tetrabenazine, a vesicular monoamine transporter (VMAT2) blocker. By
increasing cytoplasmic dopamine, VMAT2 blockade increases the likelihood of reverse
transport of dopamine by DAT (Jones et al. 1999, Jones et al. 1998, Leviel 2001). Rats
received an intravenous injection of vehicle and voltammograms were recorded for 10
minutes.
Events around the tetrabenazine injection from a single animal are illustrated in Figure 4A–
C. Thirty minutes after tetrabenazine administration, electrically evoked dopamine release
was attenuated without affecting the simultaneously measured pH change (compare Figure
2A and C). The decrease in stimulated dopamine release was statistically significant when
evaluated in all animals (Figure 4D). Following tetrabenazine injection, dopamine changes
can be seen both in the color plot recorded 4–6 minutes after tetrabenazine and in the cyclic
voltammogram constructed by subtracting those recorded 5 min after tetrabenazine from
those recorded before its administration (Figure 4B). Data were continuously collected for
an additional 30 minutes following injection and analyzed as described above. In this
interval spontaneous dopamine transients disappeared (Figure 4E). Vehicle injection did not
alter stimulated release or the number of spontaneous dopamine transients observed (Figure
4D, E).
In a separate group of animals, GBR12909 was injected i.v. followed 10 minutes later by
tetrabenazine. Our intention was to use a DAT inhibitor to reduce the possibility of reverse
transport. The subsequent injection of tetrabenazine restored both the electrically evoked
stimulated dopamine release and frequency of transients to pre-GBR 12909 levels, figure
4D, E. However, in the first 5 minutes after tetrabenazine, dopamine continued to increase
(data not shown).
DISCUSSION
Dopamine neurons exhibit both phasic and tonic cell firing patterns (Floresco et al. 2003,
Grace & Bunney 1984b, Grace & Bunney 1984a, Schultz et al. 1993). The extracellular
level of dopamine concentration could reflect tonic or phasic firing of dopamine neurons or
both. Since transients reflect phasic firing (Sombers et al. 2009), we assayed their
contribution to the extracellular level of dopamine. We determined the mean dopamine
concentration contributed by phasic firing by signal averaging spontaneous dopamine
transients over multiple minutes, a time scale compatible with microdialysis sampling. In
two separate groups of rats, we found that the average dopamine concentration contributed
by phasic firing is ~20 nM for an awake rat at rest. The contribution of dopamine cell firing
in general was probed on a shorter time scale by inactivation of dopamine cell bodies in the
VTA with lidocaine microinfusion. The absence of an appreciable decrement in dopamine
concentration during the infusion and immediately thereafter indicates that the contribution
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of tonic firing to the extracellular level was below our detection limit. The lidocaine
microinfusions were clearly effective since electrically evoked dopamine release was
blocked and the frequency of transients was diminished. Indeed, when signal averaged over
many minutes, the dopamine concentration contributed from phasic firing was significantly
lower after lidocaine treatment. Inhibition of either DAT or VMAT2 caused increases in
extracellular dopamine in the 500 nM range, indicating the important role that these two
transporters play in maintaining low extracellular dopamine concentrations.
Attempts to measure the basal concentration of dopamine have led to a variety of estimates.
The value of the extracellular dopamine concentration depends upon the time and space
scale of the measurement. For example, if the level was taken as that at the exocytotic fusion
pore, a value of greater than 100 mM would be obtained (Kawagoe et al. 1992). However,
this concentration rapidly decreases with distance from the release site due to dilution in the
extracellular fluid. Here, we are interested in the extracellular concentration found on a
length scale of 100s of micrometers and a time scale of minutes. This value is fundamentally
important to understand normal receptor occupancy and the changes that can occur during
dopamine transients (Arbuthnot and Wickens, 2007; Dreyer et al. 2010). One approach has
been to evaluate the competition between endogenous dopamine and radio-labeled agonists
(Ross 1991, Delforge et al. 2001). This procedure, which depends upon known values for
agonist binding, has led to estimates of basal dopamine concentrations in the 50–100 nM
range. A more direct approach is the use of in vivo microdialysis in which the extracellular
fluid is sampled with an implanted dialysis membrane (Watson et al. 2006). To minimize the
effects of concentration gradients, two variants of this technique have been employed. The
no-net flux method, which employs a known amount of the analyte of interest in the
perfusion buffer, has yielded extracellular dopamine concentration of 5 nM (Parsons &
Justice 1992). The extrapolation to zero flow method employs multiple flow rates to allow
extrapolation to the value in the absence of flow. The Kennedy group reported a striatal
extracellular dopamine concentration of 18 nM using a low flow rate procedure (Shou et al.
2006). However, when the damage caused by probe insertion is considered, theoretical
models of microdialysis have suggested that these values are an underestimate of the true
extracellular dopamine concentration (Peters & Michael 1998, Bungay et al. 2003).
Carbon-fiber microelectrodes are much smaller than microdialysis probes so they cause less
tissue damage (Peters et al. 2004). Unlike classic, slow-scan techniques, fast-scan cyclic
voltammetry provides a distinct signal for dopamine that differs from that for
dihydroxyphenylacetic acid, the major dopamine metabolite (Heien et al. 2004).
Furthermore, the method provides subsecond time resolution for catecholamine
concentration changes. However, measurements with rapid electrochemical methods have a
large background that requires background subtraction to reveal dopamine changes
(Keithley et al. 2011, Millar et al. 1985). This prevents direct measurement of the
extracellular concentration. For example, the amplitude of the current for 100 nM dopamine
is only ~0.1 % of the background current. In addition to the large background, drift in the
background signal prevents accurate background subtraction unless drift is accounted for in
the principal component regression (Hermans et al. 2008).
It has previously been suggested that a portion of the dopamine collected with microdialysis
arises from dopamine released by phasic firing (Robinson et al. 2009, Floresco et al. 2003).
To estimate this fraction on the time scale of microdialysis, we averaged multiple recordings
over 15 min. Before averaging, each 30 s epoch of data was background subtracted using the
cyclic voltammograms that had the lowest current at 0.65 V, the peak potential for dopamine
oxidation. This averaging procedure accounts for all of the rapidly fluctuating dopamine
extracted by principal component regression. The result shown in Figure 1 (and replicated in
Figure 2 with a completely different group of subjects) strongly suggests that microdialysis
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estimates of the basal dopamine concentration include a significant contribution from
dopamine released by phasic firing. Indeed, our averaged dopamine concentration, ~20 nM,
is well within the range of multiple estimates made by microdialysis. Note, however, this
concentration does not include the contribution from tonic firing because of the background
subtraction procedure.
The concentration measured by the averaging procedure is the average working range for
normal dopamine signaling contributed by phasic firing. We used lidocaine microinfusions
into the VTA to distinguish whether tonic or phasic firing further contributes to the average
extracellular dopamine concentration. Inactivation of dopamine neurons with lidocaine
resulted in a significant decrease of extracellular dopamine in the NAc when measured on a
minutes time scale with microdialysis (Howland et al. 2002). Indeed, lidocaine acts rapidly
as shown following injection into the primate cerebral cortex where a 60% decrease in
neuronal firing rates occurred within 60 s (Tehovnik & Sommer 1997). As we have
previously shown, lidocaine microinfusions into the VTA rapidly eliminates spontaneous
transients and stimulated release (Sombers et al. 2009). We anticipated that the cessation of
release arising from inhibition of firing of dopaminergic neurons would lead to an
immediate disappearance of extracellular dopamine contributed by tonic firing, leading to a
rapid decrease in dopamine concentration that would not be distorted by the drift of the
electrode response. Without ongoing tonic release activity, the DAT would remove all
extracellular dopamine in less than a second. However, the voltammetric recordings showed
no detectable change in the dopamine signal in the 60 s interval following the microinfusion.
Thus, the contribution from tonic firing must be in the low nanomolar range, below our
previous theoretical estimate of 30 nM (Venton et al. 2003). Our estimate was based on a
release amplitude that was obtained during electrically stimulated release of dopamine.
However, the measurements following lidocaine microinfusion in the VTA, with a method
that has a detection limit of ~10 nM dopamine for single voltammetric scans (Heien et al.
2003), clearly indicate that extracellular dopamine concentration is very low. When the time
scale is increased to 10 min by averaging dopamine responses following microinfusion, a
reduction in the dopamine concentration was found relative to pre-microinfusion levels and
the frequency of transients diminished. Since the frequency of transients was not totally
suppressed following lidocaine, the time-averaged concentration after lidocaine likely
reflects a phasic contribution.
We used intravenous pharmacological treatments to block two of the central transporters
involved in the regulation of extracellular dopamine. Global inhibition of both DAT and
VMAT2 led to a substantial increase in extracellular dopamine that approached 500 nM.
Following DAT inhibition with GBR 12909 the increased extracellular level was
accompanied by robust dopamine transients. This behavior is also seen for NAc dopamine
following nomifensine (Robinson & Wightman 2004) or cocaine (Heien et al. 2005). For
cocaine, the transients have been shown to depend on continued phasic firing of
dopaminergic neurons in the VTA (Sombers et al. 2009). Following VMAT2 inhibition with
tetrabenazine, the substantial dopamine increase is not accompanied by dopamine transients.
The absence of transients is due to the different mechanism of release evoked by
tetrabenazine: the continuous outpouring of dopamine arises from its reversed transport from
the cytoplasm by the DAT (Jones et al. 1999), a process that is independent of neuronal
firing. Consistent with this, when tetrabenazine was given after inhibition of the DAT,
transients were still apparent and stimulated dopamine release was not suppressed. Reverse
transport has been suggested to maintain high extracellular levels under normal conditions
(Borland & Michael 2004). Our results demonstrate that reverse transport can lead to high
extracellular dopamine levels but only when there are abnormally high cytoplasmic levels of
dopamine.
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Taken together, our data suggest that the extracellular level of dopamine - observed as a
function of averaging over time and space – is largely established by phasic dopamine
release. The data indicate that the sum of phasic and tonic dopamine in the NAc of awake
freely-moving rats is in the range of 20–30 nM when measured on a time scale of multiple
minutes which is in accordance with the range reported by many quantitative microdialysis
studies (Justice 1993, Shou et al. 2006). Thus, these results reconcile the results from
microdialysis with those measured by in vivo voltammetry. The contribution from tonic
firing was difficult to quantify with the methods used here. A basal dopamine level certainly
exists since the delivery of some aversive stimuli, known to cause an inhibition of firing of
dopamine neurons (Mirenowicz & Schultz 1996), cause a decrease in dopamine levels of
approximately 10 nM (Roitman et al. 2008, Wheeler et al. 2011). The high affinity forms of
dopamine receptors are activated by relatively low concentrations (approximately 10 nM),
but activation of the low affinity forms requires a much higher (on the order of 1 μM)
dopamine concentration (Richfield et al. 1989, Neve & Neve 1997). Thus, for phasic
transient events, which are in the 40–100 nM range (Wightman et al. 2007), to have
physiological importance, the extracellular, steady state concentration of dopamine needs to
be fairly low. Our data are consistent with several theoretical models that predict a normally
low extracellular dopamine concentration that is controlled by the balance between release
and uptake (Dreyer et al. 2010, Arbuthnott & Wickens 2007).
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Time-averaged Phasic Dopamine Signaling. A) Top, dopamine concentration fluctuations
over a single 30 s epoch extracted from raw data using principal component regression.
Bottom, 30 s of background-subtracted cyclic voltammograms showing dopamine transients
at various time points. B) Top, the mean ± SEM dopamine concentration over the 30 s epoch
averaged first across 15 min for each rat and then across all 9 rats. Bottom, color
representation of the averaged, background-subtracted cyclic voltammograms. C) The
coefficient of variation (CV) for different time bins (0.1 to 30 s) for one rat. D) the average
CV across rats (n=9) when bins are either 0.1 (raw) or 30 (time averaged) s.
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Intra-VTA injection of lidocaine. A. Stimulated dopamine release and pH -changes are
shown with the color plot from which they were extracted by principal component analysis.
B. Dopamine and pH with corresponding colorplot, during and after a one minute lidocaine
microinfusion. C. Dopamine and pH response to electrical stimulation post lidocaine
infusion. D. The average dopamine baseline pre saline and lidocaine ~ 22 nM. E. Average
dopamine baseline after saline microinfusion into the VTA. F. Average dopamine baseline
after lidocaine infusion. G. [DA]stim measured pre-drug, post saline and post lidocaine.
Lidocaine significantly reduced dopamine release, one-way ANOVA, P < 0.05, F5.54 = 2.
Frequency of spontaneous transient dopamine release transients measured pre-drug, post
saline and post lidocaine. Lidocaine significantly reduced the frequency of transients, one-
way ANOVA, P < 0.01, F4.61 = 2, (n=7).
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Intravenous GBR12909. A. Electrically evoked dopamine and pH response pre GBR12909
injection with corresponding colorplot. B. Colorplot representation of extracellular
dopamine. The cyclic voltammogram was recorded 5 min after GBR12909 administration.
C. Dopamine and pH response to electrical stimulation 30 minutes after GBR12909
injection. D. Electrically evoked dopamine release pre-drug, after vehicle and after
GBR12909. GBR12909 significantly increases dopamine release, one-way ANOVA, P <
0.01, F 6.25= 2, compared to pre-drug. E. Frequency of spontaneous transient dopamine
release events, pre-drug, post vehicle and post GBR12909. GBR12909 significantly increase
the frequency of transients, one-way ANOVA, P < 0.001, F12.78 = 2, (n = 5).
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Intravenous tetrabenazine. A. Stimulated dopamine release and pH -changes are shown with
the color plot from which they were extracted by principal component analysis. B. Color
plot of voltammograms recorded 4–6 min after an i.v. injection of tetrabenazine. C.
Dopamine and pH response to electrical stimulation 30 min after tetrabenazine. D. [DA]stim
measured pre-drug, after vehicle, after tetrabenazine, and after GBR12909 followed by
tetrabenazine. Tetrabenazine significantly reduced stimulated dopamine release, one-way
ANOVA, P < 0.01, F 17.75= 2, E. Frequency of spontaneous transient dopamine release
transients measured pre-drug, post vehicle, after tetrabenazine and after GBR12909
followed by tetrabenazine. Tetrabenazine significantly reduced the frequency of transients,
one-way ANOVA, P < 0.01, F 20.24= 2, (n=5).
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